Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
AMG 133 clinical trials
13 selected ClinicalTrials.gov records carrying the official matched intervention AMG 133 (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
13 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 4 selected PubMed records and 0 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT06660173
PeptideScanner retained ClinicalTrials.gov record NCT06660173 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-11, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.
- PeptideScanner change date
- November 14, 2026
- Cited source date
- September 11, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT06858839
PeptideScanner retained ClinicalTrials.gov record NCT06858839 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-17, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.
- PeptideScanner change date
- November 14, 2026
- Cited source date
- September 17, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT07310563
PeptideScanner retained ClinicalTrials.gov record NCT07310563 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.
- PeptideScanner change date
- November 14, 2026
- Cited source date
- October 13, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Maridebart cafraglutide · 2026-11-09
ClinicalTrials.gov record NCT07871409
Recruiting at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-11-06
ClinicalTrials.gov record NCT07921316
Not yet recruiting at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-11-02
ClinicalTrials.gov record NCT07908316
Recruiting at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-10-13
ClinicalTrials.gov record NCT07310563
Completed at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-09-22
ClinicalTrials.gov record NCT07832799
Not yet recruiting at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-09-17
ClinicalTrials.gov record NCT06858839
Active, not recruiting at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-09-11
ClinicalTrials.gov record NCT06660173
Active, not recruiting at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-09-03
ClinicalTrials.gov record NCT07684144
Recruiting at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-08-27
ClinicalTrials.gov record NCT07575399
Recruiting at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-08-07
ClinicalTrials.gov record NCT07313761
Completed at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-08-04
ClinicalTrials.gov record NCT07684235
Recruiting at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-07-24
ClinicalTrials.gov record NCT07037433
Recruiting at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-07-02
ClinicalTrials.gov record NCT07037459
Recruiting at the retained observation.
Open attributed record →